智通财经APP讯,西藏药业(600211.SH)披露2024年第一季度报告,报告期公司实现营收7.04亿元,同比下降22.35%;归母净利润3.13亿元,同比增长3.21%;扣非净利润2.35亿元,同比下降19.75%。基本每股收益1.26元。
特别声明:以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布,本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.